Who we are
Dovetail Genomics is enabling researchers to solve tomorrow’s most challenging scientific problems through novel, linked-read approaches that unlock access to genomic information at unprecedented levels. Combining propriety technologies with platform solutions, services, and cutting-edge bioinformatics, our unique approaches are solving complex problems, including de novo somatic variant detection, chromatin topology analysis, chromosome-level genome assembly, and haplotype phasing. Our customers are positively impacting the fields of epigenetics, developmental biology, cancer research, evolutionary biology, infectious disease, and more.
Based in Scotts Valley, CA, Dovetail Genomics is proud to bring Bay Area Biotechnology to global markets through our distributors and partners.
Dovetail Genomics is part of Cantata Bio, a company built on a mission of continuous improvement in research tools and technologies. Cantata Bio brings together pioneering solutions like Dovetail’s genome architecture and assembly platforms, and Arc Bio’s infectious disease–focused metagenomics technology. Dovetail Genomics, part of Cantata Bio LLC is a subsidiary of EdenRoc Sciences.
Meet the Team
-
Lisa Munding, PhD
Vice President, Research and Development
-
Zack Sanborn, PhD
Senior Director, Computational Biology & Bioinformatics
-
Myriam El Khawand, PhD
Head of Customer Success
-
Sierra McWilson
Director of Global Sales and Market Development
-
Iain Russell, PhD
Director of Marketing
-
Matt Easterday, PhD, JD
CEO
-
Laura Delvin, MBA
Vice President, Business Operations for EdenRoc
-
Eric Livak Hale, PhD, Esq.
Director of Intellectual Property for EdenRoc
Careers
Here at Dovetail Genomics, we are a tight-knit community of passionate scientists and savvy business professionals who take genomics seriously while embracing the spirit of fun and collaboration.
Explore the possibilities that await you as part of a small but impactful team pushing the boundaries of science.